Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Oracle Announces Health Sciences Network

By Drug Discovery Trends Editor | July 2, 2012

Oracle announced availability of Oracle Health Sciences Network, a portfolio of integrated, cloud-based applications that enable healthcare providers and research institutions to collaborate more efficiently with life sciences organizations using de-identified healthcare information.

The solution is the result of Oracle’s close collaboration with Aurora Health Care and UPMC, which are the founding participants in Oracle Health Sciences Network.

The first two applications of Oracle Health Sciences Network, Oracle Health Sciences Protocol Validator and Oracle Health Sciences Patient Recruiter, together enable clinical investigators to rapidly identify patient cohorts, determine protocol feasibility and recruit consented patients for clinical studies based on clinical and genomic characteristics.

Oracle Health Sciences Network enables healthcare systems to actively participate in clinical research and development with life sciences companies to help provide their patients with the most advanced treatments, accelerate translational research, and bring better, safer, more targeted therapies to market more rapidly.

In developing this solution, Oracle worked closely with leading healthcare providers and life sciences companies to create a network that furthers scientific inquiry while safeguarding patient privacy.

Oracle Health Sciences Network is built on a secure, HIPAA-certified cloud to help ensure patient privacy and information security.

As the first healthcare system to work with Oracle on this initiative, Aurora Health Care played a particularly significant role in the creation of Oracle Health Sciences Network. In addition to contributing considerable expertise and resources, the organization provided consented, de-identified electronic medical records throughout the development cycle.

In addition, Oracle is also working with the Partnership to Advance Clinical Electronic Research (PACeR), a New York-based consortium of healthcare providers, academic research institutions, pharmaceutical companies and technology providers, to leverage Oracle Health Sciences Network to accelerate the realization of PACeR’s vision through technology-enabled collaboration.

PACeR will work closely with participating medical centers to assess current data capabilities and leverage technological opportunities, such as Oracle Health Sciences Network, to identify new approaches for cohort identification, protocol modeling and the collection and use of clinical information to accelerate evidence-based medical research. Oracle is an original member of PACeR.

Date: June 25, 2012
Source: Oracle


Filed Under: Drug Discovery

 

Related Articles Read More >

EVEREST lead investigator on why Dupixent sets a new bar for treating coexisting CRSwNP and asthma
Sanders, King target DTC pharma ads but the industry worries more about threats to its $2B R&D model
Zoliflodacin wins FDA nod for treatment of gonorrhea
FDA approved ENFLONSIA for the prevention of RSV in Infants
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE